CoChat

Hyperactive Factor IX Padua: A Game-Changer for Hemophilia Gene Therapy

Open access
VandenDriessche, Thierry, Chuah, Marinee K. · 2018 · Molecular Therapy
Cited by 24

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

For the past 25 years, the development of gene therapy for hemophilia has fueled technological innovations and led to emerging insights that benefited the field at large.1,2 It was particularly encouraging that sustained expression of coagulation factor IX (FIX) was achieved after liver-directed gene therapy with adeno-associated viral vectors (AAVs) in patients with severe hemophilia B.3 Neverthless, the circulating FIX levels in that study—2%–5% range of normal—fell short of preventing spontaneous and trauma-induced bleeds.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ymthe.2017.12.007

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 24

Metadata

Authors
VandenDriessche, T., & Chuah, M. K.
Venue
Molecular Therapy
Publisher
Elsevier BV
Published
2018-01
Volume
26
Issue
1
Pages
14-16
ISSN
1525-0016 (ISSN-L)
OpenAlex
W2778505513
Cited by
24
References
8
FWCI
0.36
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hyperactive Factor IX Padua: A Game-Changer for Hemophilia Gene Therapy. https://app.cochat.ai/papers/10.1016/j.ymthe.2017.12.007
The paper
VandenDriessche, T., & Chuah, M. K. (2018). Hyperactive Factor IX Padua: A Game-Changer for Hemophilia Gene Therapy. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2017.12.007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.